Menu
GeneBe

rs749140168

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 7P and 1B. PM1PM2PM5PP5BP4

The NM_000263.4(NAGLU):c.1000G>A(p.Val334Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V334F) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

NAGLU
NM_000263.4 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2

Conservation

PhyloP100: 5.39
Variant links:
Genes affected
NAGLU (HGNC:7632): (N-acetyl-alpha-glucosaminidase) This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM1
In a helix (size 15) in uniprot entity ANAG_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_000263.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr17-42541185-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 553204.We mark this variant Likely_pathogenic, oryginal submissions are: {not_provided=1, Uncertain_significance=1, Likely_pathogenic=1}.
PP5
Variant 17-42541185-G-A is Pathogenic according to our data. Variant chr17-42541185-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 623899.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Likely_pathogenic=1}.
BP4
Computational evidence support a benign effect (MetaRNN=0.39786398).. Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NAGLUNM_000263.4 linkuse as main transcriptc.1000G>A p.Val334Ile missense_variant 5/6 ENST00000225927.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NAGLUENST00000225927.7 linkuse as main transcriptc.1000G>A p.Val334Ile missense_variant 5/61 NM_000263.4 P1
NAGLUENST00000592454.1 linkuse as main transcriptc.97G>A p.Val33Ile missense_variant 1/22
NAGLUENST00000591587.1 linkuse as main transcriptc.360-1843G>A intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152162
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000240
AC:
6
AN:
250414
Hom.:
0
AF XY:
0.0000369
AC XY:
5
AN XY:
135402
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000171
AC:
25
AN:
1460936
Hom.:
0
Cov.:
32
AF XY:
0.0000206
AC XY:
15
AN XY:
726810
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000162
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152280
Hom.:
0
Cov.:
31
AF XY:
0.0000269
AC XY:
2
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.0000722
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.0000770
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Tip-toe gait Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingPractice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice PomarinoMay 02, 2018- -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2018- -
Mucopolysaccharidosis, MPS-III-B;C5569050:Charcot-Marie-Tooth disease axonal type 2V Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJul 23, 2022This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 334 of the NAGLU protein (p.Val334Ile). This variant is present in population databases (rs749140168, gnomAD 0.01%). This missense change has been observed in individual(s) with mucopolysaccarhidosis type IIIB (PMID: 33747789). ClinVar contains an entry for this variant (Variation ID: 623899). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NAGLU protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on NAGLU function (PMID: 29979746). This variant disrupts the p.Val334 amino acid residue in NAGLU. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10094189; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.071
T
BayesDel_noAF
Benign
-0.16
Cadd
Benign
19
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.61
D
Eigen
Benign
-0.10
Eigen_PC
Benign
-0.0051
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.66
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.40
T
MetaSVM
Uncertain
0.71
D
MutationAssessor
Benign
1.2
L
MutationTaster
Benign
0.86
D
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.25
N
REVEL
Uncertain
0.43
Sift
Benign
0.49
T
Sift4G
Benign
0.68
T
Polyphen
0.80
P
Vest4
0.23
MVP
0.55
MPC
0.57
ClinPred
0.11
T
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.10
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs749140168; hg19: chr17-40693203; COSMIC: COSV56795547; COSMIC: COSV56795547; API